A bacterial pneumonia vaccine approved by the Food and Drug Administration on Monday "will have limited application in this community because the incidence of bacterial pneumonia here is very low," Dr. Sholem Postel, acting director of University Health Services, said yesterday.
The F.D.A. cleared Pneumovax for market early next year. The vaccine has proven in tests to be about 80 per cent effective.
"Large-scale mass immunization will not be recommended, however, and the vaccine will be used for certain restricted groups such as the elderly in nursing homes," Postel said yesterday.
Advertisement
"It is important to note that most types of pneumonia, which is the nation's fifth leading killer, are non-bacterial," Postel added.
Want to keep up with breaking news?
Subscribe to our email newsletter.
Read more in News
E-Tickets: Alternative For Airline Travel?Recommended Articles
-
Pneumonia VaccineA group of San Francisco researchers has successfully used a vaccine to prevent pneumonia and reported their discovery in an
-
Postel, 'Cliffe Students Discuss Health CenterThe Radcliffe Health Committee conferred yesterday with Dr. Sholem Postel, Director of the Radcliffe Health Center, to discuss mutual complaints
-
More Pressure May Cause Exam DodgingThe number of students obtaining medical excuses from exams has risen for four years, but the rise cannot be attributed
-
Blast Injures 'CliffleAs Ingrid Waldron '61 started to get up from one of the stone seats in the Radcliffe Quad yesterday, she
-
UHS Begins Measles Immunization ProgramIn an effort to prevent a Boston University-style measles outbreak at Harvard, University Health Services (UHS) has begun an aggressive
-
UHS Plans to Supply Oral Polio InoculationThe University Health Services will offer Sabin oral polio vaccinations to all University personnel sometime after Christmas vacation instead of
